Showing results (931-940 of 1,177) with videos related to

Sort By:
Pageof 118
Oncotargets and Therapy|December 1, 2021
Efficacy with Trastuzumab Deruxtecan for Non-Small-Cell Lung Cancer Harboring HER2 Exon 20 Insertion Mutation in a Patient with a Poor Performance Status: A Case ReportYuki Kato, Yasuhiro Kato, Yuji Minegishi, et al.
Japanese Journal of Clinical Oncology|May 11, 2016
Interstitial lung disease associated with amrubicin chemotherapy in patients with lung cancer: a single institutional studyYukiko Miura, Yoshinobu Saito, Kenichiro Atsumi, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|December 15, 2015
Recovery of renal function after radical nephrectomy and risk factors for postoperative severe renal impairment: A Japanese multicenter longitudinal studyNaoko Kawamura, Minato Yokoyama, Yasuhisa Fujii, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 29, 2009
[Our experiences of preoperative chemoradiotherapy for rectal cancer with invasion to adjacent organs]Harunobu Sato, Koutarou Maeda, Tsunekazu Hanai, et al.
Japanese Journal of Clinical Oncology|December 4, 2018
Interstitial lung disease associated with nanoparticle albumin-bound paclitaxel treatment in patients with lung cancerTakeru Kashiwada, Yoshinobu Saito, Yasuhiro Terasaki, et al.
Anticancer Research|February 11, 2014
External validation of TNM-C score in three community hospital cohorts for clear cell renal cell carcinomaTakayuki Nakayama, Kazutaka Saito, Junichiro Ishioka, et al.
Journal of Pharmaceutical Sciences|February 12, 2014
A study on Fe(2+) - α-helical-rich keratin complex formation using isothermal titration calorimetry and molecular dynamics simulationYanyan Zhao, Jan K Marzinek, Peter J Bond, et al.
Journal of the American College of Cardiology|May 10, 2001
Assessment of noninvasive markers in identifying patients at risk in the Brugada syndrome: insight into risk stratificationT Ikeda, H Sakurada, K Sakabe, et al.
Internal Medicine (Tokyo, Japan)|May 8, 2009
Exacerbation of idiopathic interstitial pneumonias associated with lung cancer therapyYuji Minegishi, Kiyoshi Takenaka, Hideki Mizutani, et al.
BMC Cancer|December 8, 2006
Gefitinib (IRESSA) sensitive lung cancer cell lines show phosphorylation of Akt without ligand stimulationRintaro Noro, Akihiko Gemma, Seiji Kosaihira, et al.
Pageof 118